Organigram updates on Sanity Group's initial performance and Canadian market share

Organigram Global Inc. issued a business update on July 20, 2026 covering initial results from its recently acquired Sanity Group GmbH and ongoing trends in its Canadian cannabis business. Since the acquisition closed on April 15, 2026, Sanity has maintained an average market share of approximately 10% in Germany and has performed in line with revenue expectations set at the time of the deal.¹ The company also addressed a German regulatory change affecting medical cannabis reimbursement, saying the change is not expected to materially affect Sanity's business because reimbursement-based sales make up about 1% of Sanity's total revenue.¹

On the Canadian side, Organigram reported holding the #1 position in flower with 12.5% category share, #1 in vapes with 14.5% share, and #2 in pre-rolls with 7.3% share, categories that together account for more than 86% of total Canadian recreational cannabis retail sales.¹ The company also cited year-over-year share gains in beverages, up 3.1 percentage points, and concentrates, up 3.3 percentage points.¹

At the end of June, Organigram's overall Canadian recreational market share was 11.1%, down 0.4 percentage points from a year earlier but up 100 basis points sequentially from May.¹ During June specifically, the company said vape share improved about 1 percentage point from the prior month, stabilizing earlier declines in the fiscal second quarter.¹

Looking ahead, Organigram expects to report Q3 Fiscal 2026 results on or about August 11, 2026, marking the first quarter with consolidated financials including Sanity.¹ The company also plans to hold its second Digital Investor Session in late September 2026.¹